These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7114312)

  • 1. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine.
    Gualtieri CT; Lefler WH; Guimond M; Staye JI
    Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of thioridazine and withdrawal dyskinesias on workshop performance of mentally retarded young adults.
    Breuning SE; Davis VJ; Matson JL; Ferguson DG
    Am J Psychiatry; 1982 Nov; 139(11):1447-54. PubMed ID: 6753612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total dosage of chlorpromazine and ocular opacities.
    Buffaloe WJ; Johnson AW; Sandifer MG
    Am J Psychiatry; 1967 Aug; 124(2):250-1. PubMed ID: 4951587
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the acoustic reflex threshold in institutionalized retarded adults taking mellaril and/or thorazine.
    Niswander PS; Helfner-Mitchell F
    Ear Hear; 1988 Feb; 9(1):9-14. PubMed ID: 3342946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deposits in the lens and cornea of the eye during long-term chlorpromazine medication.
    Rasmussen K; Kirk L; Faurbye A
    Acta Psychiatr Scand; 1976 Jan; 53(1):1-6. PubMed ID: 1251751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of single-double blind procedures, maintenance of placebo effects and drug induced dyskinesia with mentally retarded persons.
    Breuning SE; Ferguson DG; Cullari S
    Appl Res Ment Retard; 1980; 1(3-4):175-92. PubMed ID: 7337456
    [No Abstract]   [Full Text] [Related]  

  • 7. Opacities and thioridazine.
    Westlin WF
    Am J Psychiatry; 1983 May; 140(5):658-9. PubMed ID: 6846614
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of prolonged phenothiazine intake on psychotic and other hospitalized children.
    McAndrew JB; Case Q; Treffert DA
    J Autism Child Schizophr; 1972; 2(1):75-91. PubMed ID: 5067403
    [No Abstract]   [Full Text] [Related]  

  • 9. Ocular changes produced by chlorpromazine.
    Dencker SJ; Enoksson P
    Acta Ophthalmol (Copenh); 1966; 44(3):397-403. PubMed ID: 5953234
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocular changes associated with chlorpromazine therapy. A preliminary report.
    Edler K
    Acta Ophthalmol (Copenh); 1966; 44(3):405-9. PubMed ID: 5953235
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
    [No Abstract]   [Full Text] [Related]  

  • 12. Asymmetric anterior segment changes induced by chlorpromazine.
    Deluise VP; Flynn JT
    Ann Ophthalmol; 1981 Aug; 13(8):953-5. PubMed ID: 7294636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
    Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM
    Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical evaluation of mesoridazine in mentally retarded patients.
    Zaleski W
    Can Psychiatr Assoc J; 1970 Jun; 15(3):319-22. PubMed ID: 4913609
    [No Abstract]   [Full Text] [Related]  

  • 15. Eye findings in patients with phenylketonuria.
    Zwaan J
    Arch Ophthalmol; 1983 Aug; 101(8):1236-7. PubMed ID: 6882253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic effects of phenothiazines on the eye.
    Boet DJ
    Doc Ophthalmol; 1970 Jul; 28(1):1-69. PubMed ID: 5312274
    [No Abstract]   [Full Text] [Related]  

  • 17. Ocular (pigmentary) effects of psychotropic drugs.
    Appleton WS; Shader RI; DiMascio A
    Conn Med; 1970 Jan; 34(1):25-8. PubMed ID: 4903792
    [No Abstract]   [Full Text] [Related]  

  • 18. Kerato-lenticular ocular deposits and visual impairment with prolonged chlorpromazine use: A case series.
    Gowda GS; Hegde A; Shanbhag V; Narayanaswamy JC; Jaisoorya TS
    Asian J Psychiatr; 2017 Feb; 25():188-190. PubMed ID: 28262147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of the ocular side effects of chlorpromazine in the Tuscaloosa Veterans Administration patient population.
    Alexander LJ; Bowerman L; Thompson LR
    J Am Optom Assoc; 1985 Nov; 56(11):872-6. PubMed ID: 4078212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines.
    Paulson GW; Rizvi CA; Crane GE
    Clin Pediatr (Phila); 1975 Oct; 14(10):953-5. PubMed ID: 1100296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.